Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 09:16 am Sale | 2024-12-31 | 13G | Blueprint Medicines Corporation BPMC | FMR CORP | 2,247,679 3.500% | -2,100,632 (-48.31%) | Filing History |
| 2024-11-14 1:22 pm Sale | 2024-09-30 | 13G | Blueprint Medicines Corporation BPMC | PRICE T ROWE ASSOCIATES INC | 5,387,267 8.500% | -863,556 (-13.82%) | Filing History |
| 2024-04-10 12:58 pm Purchase | 2024-03-31 | 13G | Blueprint Medicines Corporation BPMC | PRICE T ROWE ASSOCIATES INC | 6,250,823 10.200% | 815,206 (+15.00%) | Filing History |
| 2024-02-14 10:03 am Purchase | 2023-12-31 | 13G | Blueprint Medicines Corporation BPMC | PRICE T ROWE ASSOCIATES INC | 5,435,617 8.900% | 1,136,327 (+26.43%) | Filing History |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | Blueprint Medicines Corporation BPMC | FMR CORP | 4,348,311 7.153% | -324,800 (-6.95%) | Filing History |
| 2024-02-08 10:11 am Sale | 2023-12-29 | 13G | Blueprint Medicines Corporation BPMC | WELLINGTON MANAGEMENT CO LLP | 4,276,333 7.030% | -727,095 (-14.53%) | Filing History |
| 2024-01-24 09:46 am Purchase | 2023-12-31 | 13G | Blueprint Medicines Corporation BPMC | BLACKROCK INC BLK | 6,584,176 10.800% | 309,654 (+4.94%) | Filing History |
| 2024-01-10 10:16 am Purchase | 2023-12-29 | 13G | Blueprint Medicines Corporation BPMC | The Vanguard Group | 6,114,970 10.060% | 340,514 (+5.90%) | Filing History |
| 2023-11-13 09:02 am Sale | 2023-11-10 | 13G | Blueprint Medicines Corporation BPMC | FMR CORP | 4,673,111 7.687% | -4,301,434 (-47.93%) | Filing History |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | Blueprint Medicines Corporation BPMC | PRICE T ROWE ASSOCIATES INC | 4,299,290 7.200% | -251,249 (-5.52%) | Filing History |
| 2023-02-09 11:12 am Purchase | 2022-12-30 | 13G | Blueprint Medicines Corporation BPMC | The Vanguard Group | 5,774,456 9.650% | 240,685 (+4.35%) | Filing History |
| 2023-02-09 08:23 am Purchase | 2023-02-09 | 13G | Blueprint Medicines Corporation BPMC | FMR CORP | 8,974,545 14.999% | 2,941,866 (+48.77%) | Filing History |
| 2023-02-06 2:49 pm Purchase | 2022-12-30 | 13G | Blueprint Medicines Corporation BPMC | WELLINGTON MANAGEMENT CO LLP | 5,003,428 8.360% | 1,526,103 (+43.89%) | Filing History |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Blueprint Medicines Corporation BPMC | BLACKROCK INC BLK | 6,274,522 10.500% | 0 (Unchanged) | Filing History |
| 2023-01-20 09:43 am Purchase | 2022-12-31 | 13G | Blueprint Medicines Corporation BPMC | BLACKROCK INC BLK | 6,274,522 10.500% | 281,919 (+4.70%) | Filing History |
| 2022-11-09 3:21 pm Purchase | 2022-10-31 | 13G | Blueprint Medicines Corporation BPMC | BLACKROCK INC BLK | 5,992,603 10.000% | 655,729 (+12.29%) | Filing History |
| 2022-05-10 10:13 am Purchase | 2022-05-09 | 13G | Blueprint Medicines Corporation BPMC | FMR CORP | 6,032,679 10.126% | 3,684,227 (+156.88%) | Filing History |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | Blueprint Medicines Corporation BPMC | PRICE T ROWE ASSOCIATES INC | 4,550,539 7.700% | 862,773 (+23.40%) | Filing History |
| 2022-02-09 3:33 pm Purchase | 2021-12-31 | 13G | Blueprint Medicines Corporation BPMC | The Vanguard Group | 5,533,771 9.410% | 347,259 (+6.70%) | Filing History |
| 2022-02-09 09:09 am Sale | 2022-02-08 | 13G | Blueprint Medicines Corporation BPMC | FMR CORP | 2,348,452 3.991% | -1,841,923 (-43.96%) | Filing History |